Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.
Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check26 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.SummaryDifference4%
- Check34 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check48 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check69 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check91 days agoChange DetectedThe website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).SummaryDifference6%
Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.